How much revenue did Xencor generate this year?
Xencor has achieved a revenue of 69.4 M USD this year.
Xencor Revenue 2024
Xencor Revenue
69.4 M USD
Ticker
XNCR
ISIN
US98401F1057
WKN
A1W96L
In 2024, Xencor's sales reached 69.4 M USD, a -58.77% difference from the 168.34 M USD sales recorded in the previous year.
The Xencor Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2029e | 501.44 | - |
| 2028e | 356.68 | - |
| 2027e | 314.46 | - |
| 2026e | 165.31 | - |
| 2025e | 109.02 | - |
| 2024e | 69.4 | - |
| 2023 | 168.34 | - |
| 2022 | 164.6 | - |
| 2021 | 275.1 | - |
| 2020 | 122.7 | - |
| 2019 | 156.7 | - |
| 2018 | 40.6 | - |
| 2017 | 46.2 | - |
| 2016 | 109 | - |
| 2015 | 27.8 | - |
| 2014 | 9.5 | - |
| 2013 | 10.2 | - |
| 2012 | 9.5 | - |
| 2011 | 6.8 | - |
Xencor Revenue, EBIT, Net Income US98401F1057 · A1W96L
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Xencor, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Xencor from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Xencor’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Xencor. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Xencor’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Xencor’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Xencor’s growth potential.
Xencor Revenue, EBIT and net profit per share
| Date | Xencor Revenue | Xencor EBIT | Xencor Net Income |
|---|---|---|---|
| 2029e | 501.44 M undefined | 0 undefined | 97.48 M undefined |
| 2028e | 356.68 M undefined | -58.38 M undefined | 0 undefined |
| 2027e | 314.46 M undefined | -69.99 M undefined | -32.23 M undefined |
| 2026e | 165.31 M undefined | -97.84 M undefined | -169.63 M undefined |
| 2025e | 109.02 M undefined | -206.58 M undefined | -227.06 M undefined |
| 2024e | 69.4 M undefined | -239.92 M undefined | -255.94 M undefined |
| 2023 | 168.34 M undefined | -137.34 M undefined | -126.09 M undefined |
| 2022 | 164.6 M undefined | -82.5 M undefined | -55.2 M undefined |
| 2021 | 275.1 M undefined | 43.8 M undefined | 82.6 M undefined |
| 2020 | 122.7 M undefined | -76.8 M undefined | -69.3 M undefined |
| 2019 | 156.7 M undefined | 13.8 M undefined | 26.9 M undefined |
| 2018 | 40.6 M undefined | -79.4 M undefined | -70.4 M undefined |
| 2017 | 46.2 M undefined | -43.1 M undefined | -38.5 M undefined |
| 2016 | 109 M undefined | 44 M undefined | 45.1 M undefined |
| 2015 | 27.8 M undefined | -18.3 M undefined | -17.6 M undefined |
| 2014 | 9.5 M undefined | -16.5 M undefined | -16.4 M undefined |
| 2013 | 10.2 M undefined | -10.5 M undefined | 84.5 M undefined |
| 2012 | 9.5 M undefined | -6.2 M undefined | -8.6 M undefined |
| 2011 | 6.8 M undefined | -9.5 M undefined | -11.2 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2011 | 6.8 M USD | -9.5 M USD | -11.2 M USD |
| 2012 | 9.5 M USD | -6.2 M USD | -8.6 M USD |
| 2013 | 10.2 M USD | -10.5 M USD | 84.5 M USD |
| 2014 | 9.5 M USD | -16.5 M USD | -16.4 M USD |
| 2015 | 27.8 M USD | -18.3 M USD | -17.6 M USD |
| 2016 | 109 M USD | 44 M USD | 45.1 M USD |
| 2017 | 46.2 M USD | -43.1 M USD | -38.5 M USD |
| 2018 | 40.6 M USD | -79.4 M USD | -70.4 M USD |
| 2019 | 156.7 M USD | 13.8 M USD | 26.9 M USD |
| 2020 | 122.7 M USD | -76.8 M USD | -69.3 M USD |
| 2021 | 275.1 M USD | 43.8 M USD | 82.6 M USD |
| 2022 | 164.6 M USD | -82.5 M USD | -55.2 M USD |
| 2023 | 168.34 M USD | -137.34 M USD | -126.09 M USD |
| 2024e | 69.4 M USD | -239.92 M USD | -255.94 M USD |
| 2025e | 109.02 M USD | -206.58 M USD | -227.06 M USD |
| 2026e | 165.31 M USD | -97.84 M USD | -169.63 M USD |
| 2027e | 314.46 M USD | -69.99 M USD | -32.23 M USD |
| 2028e | 356.68 M USD | -58.38 M USD | 0 USD |
| 2029e | 501.44 M USD | 0 USD | 97.48 M USD |
Xencor stock margins US98401F1057 · A1W96L
The Xencor margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Xencor. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Xencor.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Xencor's sales revenue. A higher gross margin percentage indicates that the Xencor retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Xencor's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Xencor's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Xencor's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Xencor. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Xencor's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Xencor Margin History
| Xencor Gross margin | Xencor Profit margin | Xencor EBIT margin | Xencor Profit margin |
|---|---|---|---|
| 2029e | 0 % | 0 % | 19.44 % |
| 2028e | 0 % | -16.37 % | 0 % |
| 2027e | 0 % | -22.26 % | -10.25 % |
| 2026e | 0 % | -59.19 % | -102.61 % |
| 2025e | 0 % | -189.48 % | -208.27 % |
| 2024e | 0 % | -345.71 % | -368.78 % |
| 2023 | 0 % | -81.59 % | -74.9 % |
| 2022 | 0 % | -50.12 % | -33.54 % |
| 2021 | 0 % | 15.92 % | 30.03 % |
| 2020 | 0 % | -62.59 % | -56.48 % |
| 2019 | 0 % | 8.81 % | 17.17 % |
| 2018 | 0 % | -195.57 % | -173.4 % |
| 2017 | 0 % | -93.29 % | -83.33 % |
| 2016 | 0 % | 40.37 % | 41.38 % |
| 2015 | 0 % | -65.83 % | -63.31 % |
| 2014 | 0 % | -173.68 % | -172.63 % |
| 2013 | 0 % | -102.94 % | 828.43 % |
| 2012 | 0 % | -65.26 % | -90.53 % |
| 2011 | 0 % | -139.71 % | -164.71 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2011 | 0 % | -139.71 % | -164.71 % |
| 2012 | 0 % | -65.26 % | -90.53 % |
| 2013 | 0 % | -102.94 % | 828.43 % |
| 2014 | 0 % | -173.68 % | -172.63 % |
| 2015 | 0 % | -65.83 % | -63.31 % |
| 2016 | 0 % | 40.37 % | 41.38 % |
| 2017 | 0 % | -93.29 % | -83.33 % |
| 2018 | 0 % | -195.57 % | -173.4 % |
| 2019 | 0 % | 8.81 % | 17.17 % |
| 2020 | 0 % | -62.59 % | -56.48 % |
| 2021 | 0 % | 15.92 % | 30.03 % |
| 2022 | 0 % | -50.12 % | -33.54 % |
| 2023 | 0 % | -81.59 % | -74.9 % |
| 2024e | 0 % | -345.71 % | -368.78 % |
| 2025e | 0 % | -189.48 % | -208.27 % |
| 2026e | 0 % | -59.19 % | -102.61 % |
| 2027e | 0 % | -22.26 % | -10.25 % |
| 2028e | 0 % | -16.37 % | 0 % |
| 2029e | 0 % | 0 % | 19.44 % |
Xencor Aktienanalyse
What does Xencor do?
The company Xencor Inc was founded in 1997 and has since become a significant biotechnology company specializing in the development of therapeutic proteins. Xencor's goal is to develop innovative and tailored therapies for the treatment of serious diseases such as cancer and autoimmune diseases. The company is headquartered in Monrovia, California, and employs a growing number of scientists, engineers, and other professionals specialized in the development of new themes and products. Xencor has acquired a variety of patents over the years to protect its intellectual property. Its business model is based on the development of new therapeutics through its proprietary XmAb technology platform, which enables the production of highly specific polyclonal antibodies that can improve the efficiency and safety of disease treatments. Xencor has divided its business activities into various divisions, including the development of immuno-oncology products, autoimmune therapies, and new methods for the therapy of inflammatory bowel diseases. The company has developed a wide range of products, including a new class of therapeutic antibodies that mobilize and strengthen patients' own immune system to fight cancer cells. By combining these antibodies with other therapies, the effectiveness of the treatment can be further increased. In the autoimmune diseases division, Xencor has developed new therapeutics to better regulate patients' immune system and treat dangerous autoimmune conditions such as rheumatoid arthritis, multiple sclerosis, or lupus. Another focus of the company is the development of therapies for inflammatory bowel diseases such as ulcerative colitis or Crohn's disease. By developing specific antibodies involved in the inflammatory processes in the intestine, Xencor can contribute to improving the treatment of these conditions. Xencor aims to accelerate the development of new therapeutics while improving their efficacy and safety. With the help of its proprietary XmAb technology platform, the company is able to develop new drugs faster and more effectively than conventional methods. Through the combination of technology, research and development, and a high level of commitment, Xencor pursues its vision and has successfully established itself as one of the leading companies in the biotechnology industry. Xencor ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Xencor's Sales Figures
The sales figures of Xencor originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Xencor’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Xencor's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Xencor’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Xencor stock
How much was the turnover of the company Xencor compared to the previous year?
The revenue of Xencor has increased by -58.77% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Xencor?
The revenue of Xencor is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Xencor measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Xencor so important for investors?
The revenue of Xencor is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Xencor pay?
Over the past 12 months, Xencor paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Xencor is expected to pay a dividend of 0 USD.
What is the dividend yield of Xencor?
The current dividend yield of Xencor is .
When does Xencor pay dividends?
Xencor pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Xencor?
Xencor paid dividends every year for the past 0 years.
What is the dividend of Xencor?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Xencor located?
Xencor is assigned to the 'Health' sector.
Wann musste ich die Aktien von Xencor kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Xencor from 8/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 8/25/2024.
When did Xencor pay the last dividend?
The last dividend was paid out on 8/25/2024.
What was the dividend of Xencor in the year 2023?
In the year 2023, Xencor distributed 0 USD as dividends.
In which currency does Xencor pay out the dividend?
The dividends of Xencor are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Xencor stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Xencor
Our stock analysis for Xencor Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Xencor Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
